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Sunday, February 3, 2013 155ademonstrated that a restrictive proteolytic truncation of the N-terminal tension
of cardiac TnI naturally occurs in normal hearts and is up-regulated in cardiac
adaptation to hemodynamic stress or ß-adrenergic deficiency. The N-terminal
truncated cardiac TnI (cTnI-ND) alters the conformation of the core structure
of cardiac TnI, similarly to that produced with PKA phosphorylation. At organ
level, cTnI-ND enhanced ventricular diastolic function. To investigate the
functional effect of cTnI-ND at the cellular level avoiding the influence of ex-
tracellular matrix, young adult (2-3 months old) cardiomyocytes were isolated
from wild type and cTnI-ND transgenic mouse hearts and studied for morphol-
ogy, sarcomere length, shortening amplitude and velocity, and intracellular
calcium transient. Paced contractions and calcium transient were examined
using an IonOptix cell imaging system on freshly isolated cardiomyocytes in
healthy condition as shown by a positive frequency response. cTnI-ND
cardiomyocytes exhibited no difference from wild type cells in length, width
and sarcomere length, indicating an absence of pathological remodeling.
cTnI-ND cardiomyocytes exhibited larger shortening amplitude and higher
shortening/re-lengthening velocities than that of wild type cells. The amplitude
of Ca2þ transient was also higher and the durations of Ca2þ rising and decaying
were shorter in cTnI-ND myocytes vs. the control. Isoproterenol treatment sig-
nificantly increased the amplitude of contractility and calcium transient of both
wild type and cTnI-ND cardiomyocytes and diminished their differences. The
non-additive effects of cTnI-ND and ß-adrenergic stimulation suggest that
cTnI-ND enhances cardiac muscle performance via the same mechanism as
that of PKA-catalyzed N-terminal phosphorylation of intact cTnI. The func-
tional effect of cTnI-ND demonstrates a posttranslational regulatory mecha-
nism to modulate cardiac muscle contractility in physiological adaptation
and heart failure.
793-Pos Board B562
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Importance of the Highly Conserved C-Terminal Segment of Troponin I
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The C-terminal segment of troponin I (TnI) containing the last 27-33 amino
acids is highly conserved and critical for the inhibitory function of TnI. We re-
cently showed a Ca2þ-regulated interaction between this C-terminal segment of
TnI and tropomyosin (Zhang et al., FEBS J. 278:3348-59, 2011). Several mu-
tations in or near the C-terminal segment of cardiac TnI (K178E, R192H and
R204H) are found to cause restrictive cardiomyopathy in humans and con-
firmed in transgenic mice models. K179E presented a more severe phenotype
than that of R192H in transgenic mice with early lethality. Patients with cardiac
TnI-R204H mutation were presented with either hypertrophic or restrictive
cardiomyopathy. To understand the function of TnI C-terminal region in the
regulation of muscle contraction and in the pathogenesis of cardiomyopathy,
we constructed mouse cardiac TnI containing K179E, R193H or R205H muta-
tion. Using recombinant proteins, monoclonal antibody epitope analysis
demonstrated that R193H abolished a C-terminal structure highly conserved
in all TnI isoforms across vertebrate species, but did not alter calcium regulated
binding of TnI to tropomyosin in reconstituted troponin complex. R205H
resulted in a significant conformational change in the middle region troponin
C-binding helix of cardiac TnI. Mutations R193H and K179E had similar but
weaker effects. Protein binding assays showed that mutations R193H and
K179E slightly increased the binding affinity of cardiac TnI for troponin T
with statistic significance, whereas R205H drastically decreased the binding.
The binding affinity for troponin C was also very much decreased in the
R205H mutation. These results provided novel evidence for the critical func-
tion of the highly conserved C-terminal segment of TnI, in which mutations
may alter local and long-range effects on the function of the troponin complex
with major pathological impact.
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Myofilament Incorporation and Contractile Function after Gene Transfer
of Cardiac Troponin I Ser43/45Ala
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Phosphorylation of cardiac troponin I serines 43/45 (cTnISer43/45) by protein
kinase C (PKC) is associated with cardiac dysfunction, and yet there is dis-
agreement about the role this cluster plays in modulating contractile perfor-
mance. The present study evaluates the impact of phospho-null Ala
substitutions at Ser43/45 (cTnISer43/45Ala) on contractile performance in in-
tact myocytes. Viral-based gene transfer of cardiac troponin I (cTnI) or
cTnISer43/45Ala resulted in time-dependent increases in expression and 70-
80% of endogenous cTnI replaced within 4 days. Western analysis of intactand permeabilized myocytes along with immunohistochemistry showed each
exogenous cTnI was incorporated into the sarcomere within myocytes. In
contractile function studies, there were no differences in shortening and
re-lengthening for cTnI and cTnISer43/45Ala-expressing myocytes 2 days
after gene transfer. However, more extensive replacement with cTnISer43/
45Ala at 4 days diminished peak shortening amplitude and accelerated
re-lengthening measured as the time to re-lengthening at 75% (TTR75%). A de-
crease in myofilament Ca2þ sensitivity of tension also was observed in
permeabilized myocytes expressing cTnISer43/45Ala and is consistent with ac-
celerated re-lengthening observed in intact myocytes under basal conditions.
Phosphorylation of cTnI Ser23/24 and the Ca2þ transient were not changed
in these myocytes. These results demonstrate extensive sarcomere expression
of cTnISer43/45Ala directly modulates myofilament function under basal con-
ditions. In further work, the accelerated re-lengthening observed in control or
cTnI-expressing myocytes treated with the PKC agonist, endothelin-1 (ET,
10nM) was slowed in myocytes expressing cTnISer43/45Ala. This outcome
may indicate Ser43/45 is targeted for phosphorylation by ET-activated PKC
and/or influences transduction of this agonist-activated response.
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Perturbations in Protein kinase C (PKC) isoform expression and localization
have been reported in failing cardiomyocytes. Previous studies suggested
that PKC-mediated phosphorylation of cardiac troponin I (cTnI) underlies
myofilament dysfunction in cardiac disease. PKC phosphorylates cTnI at var-
ious sites; however, the functional effects of PKC-mediated cTnI phosphoryla-
tion at these different sites in human myocardium are unknown. In the present
study, we investigated the effects of cTnI phosphorylation at well-known PKC-
sites Ser42/44 and Thr143, and the recently identified PKC-site Ser199 on myo-
filament function in human failing cardiomyocytes.
Myofilament force development was measured at various [Ca2þ] and sarco-
mere lengths of 1.8 and 2.2 mm in permeabilized end-stage failing cardiomyo-
cytes in which endogenous troponin complex was partially exchanged
(66.251.6%) with recombinant whole human troponin complexes. Site-
directed mutagenesis was used to replace the Ser/Thr of the PKC-sites by as-
partic acid (D) or alanine (A) to mimic phosphorylation and dephosphorylation,
respectively. In addition, wild-type troponin (Wt) was used as a control.
Myofilament Ca2þ-sensitivity (pCa50) was significantly reduced by pseudo-
phosphorylation of Ser42/44 (pCa50=5.3650.01), while an increase was
found with pseudophosphorylated Thr143 (pCa50=5.6850.02) and Ser199
(pCa50=5.7250.01) in comparison to Wt (pCa50=5.5950.02). Only at
the Ser42/44 sites, alanine mutations affected Ca2þ-sensitivity (pCa50 =
5.5050.02) compared to Wt. The length-dependent increase in myofilament
Ca2þ-sensitivity and maximal force was not significantly affected by pseudo-
phosphorylation of the different PKC sites.
These opposite site-specific effects suggest that the collective effect of various
PKC isoforms on myofilament Ca2þ-sensitivity depends on the degree at which
the different sites are phosphorylated.
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Recombinant human cardiac actin mutants E99K, A331P, and WT were ex-
pressed in baculovirus/insect cells and used to reconstitute the thin-filament
of bovine cardiac fibers, together with tropomyosin (Tm) and troponin (Tn). Ef-
fects of [Ca2þ], [ATP], [phosphate] and [ADP] on tension and its transients
were studied at 25C. After actin filament reconstitution, tension of WT actin
reconstituted fibers reached 0.7550.06 T0 (T0: tension of native fibers), which
is comparable to rabbit skeletal actin reconstituted fibers (0.7350.07 T0).
However, tension was less in E99K (0.6050.08 T0) and A331P (0.5550.03
T0). After Tm and Tn reconstitution, tension for E99K was 0.7650.01 T0,
and A331P 0.6550.02 T0, which were less than WT (0.8550.06 T0). E99K
increased pCa50 (5.7850.03) but decreased cooperativity (1.7850.18) com-
pared with WT (5.7050.03, 2.650.3, respectively). A331P decreased pCa50
156a Sunday, February 3, 2013(5.5750.03). E99K increased TLC (tension at pCa 8.0: 0.2250.03 THC)
compared to WT (0.1050.02 THC), but A331P maintained similar TLC
(0.0850.01 THC) to WT. Five equilibrium constants of the cross-bridge
cycle were deduced using sinusoidal analysis. E99K caused a decrease in both
K0 (ADP dissociation: 16.654.6 mM
1) and K1 (ATP association:
1.5150.08 mM1) compared to WT (35.0456.3 mM1 and 2.150.3 mM1,
respectively). A331P and WT showed similar K0 (3155.4 mM
1 and
35.0456.3 mM1), K1 (1.650.2 mM
1 and 2.150.3 mM1), K2 (cross-bridge
detachment: 0.6950.1 and 0.7850.13), K4 (force generation: 0.2750.03 and
0.3450.03), and K5 (Pi association: 0.1350.2 mM
1 and 0.1250.01 mM1).
The cross-bridge distributionwas similar amongWT,E99K andA331P, indicat-
ing that force/cross-bridge is decreased in K99K and A331P. In conclusion,
E99K actin causes HCM through impaired relaxation and elevated pCa50
(diastolic problem), and lowered force/cross-bridge (systolic problem), whereas
A331P actin causes HCM through decreased pCa50 and force/cross-bridge
(systolic problem).
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Healthy heart function and structure, from the tissue to cellular scale, depends
on establishment of proper tissue mechanics. On the cellular scale, late embry-
onic, neonatal and adult cardiomyocytes exhibit mechanosensitivity to ECM
elasticity [1], such that culturing on substrates of physiological stiffness of
~10-20 kPa optimizes function. However, the heart begins functioning long be-
fore this mature mechanical environment is established. Here we examine the
effects of microenvironment mechanics on chick cardiomyocyte function dur-
ing early development, embryonic day 2-4 (E2-E4). Micropipette aspiration
measurements give an effective Young’s modulus of ~1-2 kPa at these earliest
stages. Quantitative Mass Spectroscopy of embryonic myocardium identifies
abundant structural proteins that most likely contribute to tissue mechanics.
In particular, collagen I expression parallels the mechanical stiffening of the
heart tissue. Treatment with collagenase or transglutaminase respectively
softens or stiffens heart tissue in a dose dependent manner while maintaining
functional cellular contractile machinery. Both stiffening and softening whole
heart tubes reduces tissue strain during contraction, suggesting an optimumme-
chanics for myocardial contraction even at the earliest functional stages. Con-
traction wave velocity, however, changes proportionally to the stiffness of the
tissue. E3-4 cardiomyocytes cultured on collagen-coated polyacrylamide gel
substrates of different stiffnesses are best able to contract on substrates of
~1.5 kPa, consistent with the physiological stiffness of the tissue from which
they were derived. As in the whole heart, the cells were also less able to con-
tract on much softer substrates of 300 Pa, or stiffer substrates of 10 kPa or more.
This further points to optimizing mechanics for cardiomyocyte strain that
matches the physiological stiffness of myocardium throughout development.
Finally, effects environmental mechanics on nuclear proteins during develop-
ment are being explored.
[1] Majkut SF, Discher DE. (2012). BMMB. Doi: 10.1007/s10237-012-0413-8
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Caused by the MYH7 Mutation R403Q
E. Rosalie Witjas-Paalberends1, Nicoletta Piroddi2, Beatrice Scellini2,
Ger J. Stienen1, Chiara Tesi2, Corrado Pogessi2, Jolanda van der Velden1.
1Institute for Cardiovascular Research VU University Medical Center,
Amsterdam, Netherlands, 2Dipartimento di Scienze Fisiologiche,
Firenze, Italy.
Familial hypertrophic cardiomyopathy (HCM) is frequently caused by muta-
tions in genes encoding sarcomeric proteins. Energy depletion of the heart is
thought to initiate and promote HCM disease development. It has been hypoth-
esized that HCM sarcomere gene mutations increase ATP utilization for myo-
filament contraction and thereby increase energy demand of the heart. Previous
studies in single left ventricular myofibrils from myocardium harbouring the
first identified causal HCM mutation R403Q in the gene encoding b-myosin
heavy chain revealed increased rates of tension generation and relaxation in
R403Q compared to myofibrils from healthy control myocardium. The altered
kinetics observed in the mutant sample predicted a 3-fold increase in the energy
cost of tension generation in R403Q sarcomeres. In the present study we inves-
tigated if tension cost was indeed increased in human myocardium harbouring
the R403Q mutation.
Maximal force generating capacity (Fmax) and ATP consumption (ATPmax)
were simultaneously measured in Triton-permeabilized left ventricular musclestrips (n=8) from a patient carrying the R403Q mutation. Left ventricular mus-
cle strips (n=17) from 5 HCM sarcomere mutation negative patients (HCMsmn)
and strips (n=6) from 2 patients with secondary hypertrophy due to aortic ste-
nosis (LVHao) served as a control groups. Economy of myofilament contraction
is expressed as tension cost (TC), i.e. amount of ATP used during force devel-
opment (ATPmax/Fmax). Both Fmax and ATPmax were significantly lower in
R403Q compared to HCMsmn and LVHao. TC was significantly increased in
R403Q (3.850.5 mmolL1s1/kNm2) compared to HCMsmn and LVHao
(1.650.1 and 1.750.1 mmolL1s-1/kNm2, respectively).
Our data provide direct evidence that TC is increased in myocardium harbour-
ing the MYH7 mutation R403Q, indicating that expression of R403Q in the
heart impairs economy of myocardial contraction.
Funding: Seventh Framework Program of the European Union ‘‘BIG-
HEART,’’ grant agreement 241577
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A cluster of cardiomyopathy mutation sites in b-cardiac myosin including a par-
ticularly lethal mutation of E930del can be targeted to part of the N-terminal
region of myosin subfragment-2. A peptide model of this system was synthe-
sized and labeled with resonance energy transfer probes to detect the stability
of coiled coil formation and estimates of the monomer-dimer equilibrium of the
peptide. Distance measurements between the donor and acceptor probes were
consistent with computational simulations of the labeled peptides in a coiled
coil structure which matched simulations of the unlabeled wildtype structure.
The addition of a site-specific antibody to this peptide strongly inhibited reso-
nance energy transfer, indicating that the coiled coil structure was destabilized.
In contrast, the addition of certain polyamine structures improved the stability
of the coiled coil, while other polyamines had little effect despite having signif-
icant binding constants to myosin as determined by competitive ELISA assays.
The length of the polyamine appears to be important for this ability to stabilize
the coiled coil in this region of negatively charged glutamates in the myosin
subfragment-2 sequence. Some of the polyamines may be capable of binding
both a-helixes of the myosin subfragment-2 simultaneously, thereby stabilizing
the coiled coil structure. This synthetic peptide model system holds promise as
a test system for small molecule compounds that may counteract the destabiliz-
ing effects of some cardiomyopathy mutations on the myosin coiled coil struc-
ture. (sponsored by NSF ARRA)
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Regulatory Light Chain Mutants Linked to Heart Disease affect the
Cardiac Myosin Lever-Arm
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Myosin is the chemomechanical energy transducer in striated muscle working
in the heart to circulate blood. Transduction occurs by cyclical actomyosin in-
teraction causing myosin thick filament sliding relative to the actin thin fila-
ment while consuming chemical energy from ATP. Transduction begins in
the myosin head domain or cross-bridge with ATP hydrolysis driving rotary
movement of a lever-arm converting rotation into linear translation. Myosin
regulatory light chain (RLC) binds to the lever-arm and affects its ability to
translate actin. Gene sequencing implicated several RLC mutations in human
heart disease and three of them are investigated here using single molecule
detection of photoactivatable GFP tagged RLC (RLC-PAGFP) exchanged
into permeabilized porcine papillary muscle fibers. The RLC-PAGFP detects
single lever-arm orientation. Single molecule orientation detection benefits
from new analysis tools to deduce PAGFP orientation from the 3 spatial di-
mensional fluorescence emission pattern. Experiments were performed in a mi-
crofluidic chamber designed for isometric contraction, total internal reflection
fluorescence single molecule detection, and for 2-photon excitation second
harmonic generation to evaluate sarcomere length. The RLC-PAGFP reports
discretized lever-arm orientation intermediates in active isometric fibers char-
acteristic to the wild type (WT) RLC where lever-arms occupy intermediates
on the free-energy gradient that on average correspond to the cross-bridge
stall force. Two disease linked mutants introduced to RLC move state occu-
pancy further down the free energy gradient implying lever-arms rotate
more to reach cross-bridge stall force because mutant RLC increases lever-
arm shear strain. Lower free energy states could involve strong binding that
will inhibit filament sliding in contraction. This research was supported by
NIH Institutes: NIAMS R01 AR049277 and NHLBI HL095572 and by the
Mayo Foundation.
